Discounted Cash Flow (DCF) Analysis Unlevered
China Health Industries Holdings, I... (CHHE)
$0.14
0.00 (0.00%)
All numbers are in Millions, Currency in USD
Operating Data
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 6.55 | 9.28 | 9.93 | 6.49 | 0 | 0 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
EBITDA | 0.66 | 5.51 | 5.82 | 3.04 | 0.64 | 0.10 | 0.08 | 0.06 | 0.05 | 0.04 |
EBITDA (%) | ||||||||||
EBIT | -0 | 4.69 | 5.02 | 2.16 | -0.19 | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 |
EBIT (%) | ||||||||||
Depreciation | 0.67 | 0.82 | 0.81 | 0.88 | 0.83 | 0.13 | 0.10 | 0.08 | 0.06 | 0.05 |
Depreciation (%) |
Balance Sheet Data
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Total Cash | 32.61 | 35.51 | 36.07 | 44.35 | 44.79 | 7.03 | 5.52 | 4.33 | 3.40 | 2.67 |
---|---|---|---|---|---|---|---|---|---|---|
Total Cash (%) | ||||||||||
Account Receivables | 1.49 | 2.02 | 4.66 | 2.38 | 0.04 | 0.01 | 0.01 | 0 | 0 | 0 |
Account Receivables (%) | ||||||||||
Inventories | 0.45 | 0.86 | 0.81 | 0.76 | 0.52 | 0.08 | 0.06 | 0.05 | 0.04 | 0.03 |
Inventories (%) | ||||||||||
Accounts Payable | 0.40 | 0.50 | 0.41 | 0.41 | 0.33 | 0.05 | 0.04 | 0.03 | 0.03 | 0.02 |
Accounts Payable (%) | ||||||||||
Capital Expenditure | -0.41 | -0.15 | -0.16 | -0.01 | -0 | -0 | -0 | -0 | -0 | -0 |
Capital Expenditure (%) |
Weighted Average Cost Of Capital
Share price | $ 0.14 |
---|---|
Beta | -9.431 |
Diluted Shares Outstanding | 65.54 |
Cost of Debt | |
Tax Rate | -0.84 |
After-tax Cost of Debt | 2.32% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | -40.732 |
Total Debt | 6.76 |
Total Equity | 9.18 |
Total Capital | 15.94 |
Debt Weighting | 42.42 |
Equity Weighting | 57.58 |
Wacc |
Build Up Free Cash
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 6.55 | 9.28 | 9.93 | 6.49 | 0 | 0 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|---|---|---|---|---|
EBITDA | 0.66 | 5.51 | 5.82 | 3.04 | 0.64 | 0.10 | 0.08 | 0.06 | 0.05 | 0.04 |
EBIT | -0 | 4.69 | 5.02 | 2.16 | -0.19 | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 |
Tax Rate | -489.31% | 29.50% | 29.23% | 36.13% | -0.84% | -79.06% | -79.06% | -79.06% | -79.06% | -79.06% |
EBIAT | -0.03 | 3.31 | 3.55 | 1.38 | -0.20 | -0.05 | -0.04 | -0.03 | -0.03 | -0.02 |
Depreciation | 0.67 | 0.82 | 0.81 | 0.88 | 0.83 | 0.13 | 0.10 | 0.08 | 0.06 | 0.05 |
Accounts Receivable | - | -0.53 | -2.65 | 2.28 | 2.34 | 0.03 | 0 | 0 | 0 | 0 |
Inventories | - | -0.40 | 0.05 | 0.05 | 0.24 | 0.44 | 0.02 | 0.01 | 0.01 | 0.01 |
Accounts Payable | - | 0.10 | -0.09 | 0 | -0.07 | -0.28 | -0.01 | -0.01 | -0.01 | -0.01 |
Capital Expenditure | -0.41 | -0.15 | -0.16 | -0.01 | -0 | -0 | -0 | -0 | -0 | -0 |
UFCF | 0.24 | 3.13 | 1.51 | 4.57 | 3.14 | 0.27 | 0.07 | 0.05 | 0.04 | 0.03 |
WACC | ||||||||||
PV UFCF | 0.35 | 0.11 | 0.11 | 0.11 | 0.12 | |||||
SUM PV UFCF | 0.80 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | -22.47 |
Free cash flow (t + 1) | 0.03 |
Terminal Value | -0.14 |
Present Value of Terminal Value | -0.48 |
Intrinsic Value
Enterprise Value | 0.32 |
---|---|
Net Debt | -38.03 |
Equity Value | 38.35 |
Shares Outstanding | 65.54 |
Equity Value Per Share | 0.59 |